Lupin launches generic anti-depression drug in US
New Delhi : Pharma major Lupin said it has launched generic paxil drug used for treatment of major depressive order in the US market.
The company "announced the launch of generic paxil CR extended release tablets, 12.5 mg, 25 mg and 37.5 mg, having received an approval from the United States Food and Drug Administration (FDA) earlier", Lupin said in a BSE filing.
The drug is used for treatment of major depressive, panic, social anxiety and premenstrual dysphoric disorder, it added.
The stock was trading 0.99 per cent lower at Rs 1,461 on BSE.
Next Story
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd